Hostname: page-component-74656f9884-2dmjx Total loading time: 0 Render date: 2026-11-09T02:47:57.390Z Has data issue: false hasContentIssue false

A multilevel analysis of cognitive dysfunction and psychopathology associated with chromosome 22q11.2 deletion syndrome in children

Published online by Cambridge University Press:  01 November 2005

TONY J. SIMON
Affiliation:
University of California, Davis
JOEL P. BISH
Affiliation:
Children's Hospital of Philadelphia
CARRIE E. BEARDEN
Affiliation:
University of California, Los Angeles
LIJUN DING
Affiliation:
Children's Hospital of Philadelphia
SAMANTHA FERRANTE
Affiliation:
Children's Hospital of Philadelphia
VY NGUYEN
Affiliation:
University of California, Davis
JAMES C. GEE
Affiliation:
University of Pennsylvania
DONNA M. McDONALD–McGINN
Affiliation:
Children's Hospital of Philadelphia
ELAINE H. ZACKAI
Affiliation:
Children's Hospital of Philadelphia University of Pennsylvania
BEVERLY S. EMANUEL
Affiliation:
Children's Hospital of Philadelphia University of Pennsylvania
Rights & Permissions [Opens in a new window]

Abstract

We present a multilevel approach to developing potential explanations of cognitive impairments and psychopathologies common to individuals with chromosome 22q11.2 deletion syndrome. Results presented support our hypothesis of posterior parietal dysfunction as a central determinant of characteristic visuospatial and numerical cognitive impairments. Converging data suggest that brain development anomalies, primarily tissue reductions in the posterior brain and changes to the corpus callosum, may affect parietal connectivity. Further findings indicate that dysfunction in “frontal” attention systems may explain some executive cognition impairments observed in affected children, and that there may be links between these domains of cognitive function and some of the serious psychiatric conditions, such as attention-deficit/hyperactivity disorder, autism, and schizophrenia, that have elevated incidence rates in the syndrome. Linking the neural structure and the cognitive processing levels in this way enabled us to develop an elaborate structure/function mapping hypothesis for the impairments that are observed. We show also, that in the case of the catechol-O-methyltransferase gene, a fairly direct relationship between gene expression, cognitive function, and psychopathology exists in the affected population. Beyond that, we introduce the idea that variation in other genes may further explain the phenotypic variation in cognitive function and possibly the anomalies in brain development.

We thank the children and families that participated in our studies and the staff of the 22q and You Center at the Children's Hospital of Philadelphia. This work was supported by grants from the NIH (R01HD42974 and R01HD46159) and the Philadelphia Foundation to T.J.S., Grant PO1DC02027 to B.S.E., and Grant M01-RR00240 to the Children's Hospital of Philadelphia.

Information

Type
Research Article
Copyright
© 2005 Cambridge University Press
Figure 0

Demographic information about study participants

Figure 1

The performance of children with DS22q11.2 and controls on the cueing task.

Figure 2

The performance of children with DS22q11.2 and controls on the enumeration task.

Figure 3

The performance of children with DS22q11.2 and controls on the distance effect task.

Figure 4

(a) Examples of flanker stimuli from the attentional networks test (ANT). (b) The performance of children with DS22q11.2 and controls on the executive attention component of the ANT.

Figure 5

The performance of children with DS22q11.2 and controls on the Gratton effect.

Figure 6

Voxel-based morphometry results depicting clusters of greater gray matter volumes (a) in control children than in those with DS22q11.2 and (b) in children with DS22q11.2 than in controls.

Figure 7

Voxel-based morphometry results depicting clusters of greater cerebrospinal fluid volumes in children with DS22q11.2 than in controls.

Figure 8

Voxel-based morphometry results depicting clusters of greater white matter volumes in control children than in those with DS22q11.2.

Figure 9

Voxel-based morphometry results depicting clusters of greater fractional anisotropy values (a) in control children than in those with DS22q11.2 and (b) in children with DS22q11.2 than in controls.

Figure 10

Composite depictions of clusters of greater cerebrospinal fluid volumes in children with DS22q11.2 along with clusters of greater fractional anisotropy values (a) in control children and (b) in the same children.